Qian Wei-Jun, Kaleta David T, Petritis Brianne O, Jiang Hongliang, Liu Tao, Zhang Xu, Mottaz Heather M, Varnum Susan M, Camp David G, Huang Lei, Fang Xiangming, Zhang Wei-Wei, Smith Richard D
Biological Sciences Division and Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington 99352, USA.
Mol Cell Proteomics. 2008 Oct;7(10):1963-73. doi: 10.1074/mcp.M800008-MCP200. Epub 2008 Jul 15.
The enormous dynamic range of human bodily fluid proteomes poses a significant challenge for current MS-based proteomics technologies as it makes it especially difficult to detect low abundance proteins in human biofluids such as blood plasma, which is an essential aspect for successful biomarker discovery efforts. Here we present a novel tandem IgY12-SuperMix immunoaffinity separation system for enhanced detection of low abundance proteins in human plasma. The tandem IgY12-SuperMix system separates approximately 60 abundant proteins from the low abundance proteins in plasma, allowing for significant enrichment of low abundance plasma proteins in the SuperMix flow-through fraction. High reproducibility of the tandem separations was observed in terms of both sample processing recovery and LC-MS/MS identification results based on spectral count data. The ability to quantitatively measure differential protein abundances following application of the tandem separations was demonstrated by spiking six non-human standard proteins at three different levels into plasma. A side-by-side comparison between the SuperMix flow-through and IgY12 flow-through samples analyzed by both one- and two-dimensional LC-MS/MS revealed a 60-80% increase in proteome coverage as a result of the SuperMix separations, suggesting significantly enhanced detection of low abundance proteins. A total of 695 plasma proteins were confidently identified in a single analysis (with a minimum of two peptides per protein) by coupling the tandem separation strategy with two-dimensional LC-MS/MS, including 42 proteins with reported normal concentrations of approximately 100 pg/ml to 100 ng/ml. The concentrations of two selected proteins, macrophage colony-stimulating factor 1 and matrix metalloproteinase-8, were independently validated by ELISA as 202 pg/ml and 12.4 ng/ml, respectively. Evaluation of binding efficiency revealed that 45 medium abundance proteins were efficiently captured by the SuperMix column with >90% retention. Taken together, these results illustrate the potential broad utilities of this tandem IgY12-SuperMix strategy for proteomics applications involving human biofluids where effectively addressing the dynamic range challenge of the specimen is imperative.
人类体液蛋白质组的巨大动态范围对当前基于质谱的蛋白质组学技术构成了重大挑战,因为这使得在诸如血浆等人类生物流体中检测低丰度蛋白质变得尤为困难,而这是成功发现生物标志物的关键环节。在此,我们展示了一种新型的串联IgY12 - SuperMix免疫亲和分离系统,用于增强对人血浆中低丰度蛋白质的检测。串联IgY12 - SuperMix系统将血浆中的约60种高丰度蛋白质与低丰度蛋白质分离,使得SuperMix流通组分中的低丰度血浆蛋白质得到显著富集。基于光谱计数数据,在样品处理回收率和液相色谱 - 串联质谱(LC - MS/MS)鉴定结果方面,均观察到串联分离具有高重现性。通过在血浆中加入三种不同水平的六种非人类标准蛋白质,证明了串联分离后定量测量差异蛋白质丰度的能力。通过一维和二维LC - MS/MS对SuperMix流通样品和IgY12流通样品进行并行比较,结果显示由于SuperMix分离,蛋白质组覆盖率提高了60 - 80%,这表明低丰度蛋白质的检测得到了显著增强。通过将串联分离策略与二维LC - MS/MS相结合,在单次分析中可靠地鉴定出了总共695种血浆蛋白质(每种蛋白质至少有两个肽段),其中包括42种报告正常浓度约为100 pg/ml至100 ng/ml的蛋白质。通过酶联免疫吸附测定(ELISA)独立验证了两种选定蛋白质巨噬细胞集落刺激因子1和基质金属蛋白酶 - 8的浓度,分别为202 pg/ml和12.4 ng/ml。结合效率评估显示,45种中等丰度蛋白质被SuperMix柱有效捕获,保留率>90%。综上所述,这些结果说明了这种串联IgY12 - SuperMix策略在涉及人类生物流体的蛋白质组学应用中的潜在广泛用途,在这些应用中有效应对样本的动态范围挑战至关重要。